NRAS and metabolic dysfunction-associated steatohepatitis: N-RAS in liver samples of patients with NASH undoubtedly indicated a progressive loss of this protein during the course of liver fibrosis, which was in line with the exacerbated fibrosis observed in mice deficient for N-RAS upon induced liver damage.